nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['rcc,(-irccs),(-srcc),(-urcc)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'biomarker', 'cabo ', 'nivo', 'marker ']
exciting session at #gu23; need for biomarkers to guide therapy in rcc. insightful discussion by to discover potential biomarkers of response to nivo/cabo 
Assistant Professor Harvard Medical School; Director of Clinical Research, Lank Center for GU Oncology DFCI COI -coi.asco.org/share/EXE-GEFM…